Comment la Sclérose Latérale Amyotrophique contribue à augmenter le risque de thromboembolie veineuse
DOI :
https://doi.org/10.62438/tunismed.v103i3.5734Mots-clés :
amyotrophic lateral sclerosis, anticoagulant, neurodegenerative diseases, pulmonary embolism, venous thromboembolismRésumé
.
Téléchargements
Références
Immobile ALS patients or those at risk of venous thromboembolism require a comprehensive examination and low-dose heparinisation. Tunis Med.
Hamad AA, Alkhawaldeh IM, Abbas A, et al. Incidence and risk factors of venous thromboembolism in patients with amyotrophic lateral sclerosis: a systematic review and meta-analysis. Tunis Med 2024; 102: 610–615.
Goldacre R, Trubshaw M, Morris EJA, et al. Venous thromboembolism risk in amyotrophic lateral sclerosis: a hospital record-linkage study. J Neurol Neurosurg Psychiatry 2024; jnnp-2024-333399.
Lu C-H, Allen K, Oei F, et al. Systemic inflammatory response and neuromuscular involvement in amyotrophic lateral sclerosis. Neurol Neuroimmunol Neuroinflammation; 3. Epub ahead of print August 2016. DOI: 10.1212/NXI.0000000000000244.
Branchford BR, Carpenter SL. The Role of Inflammation in Venous Thromboembolism. Front Pediatr; 6. Epub ahead of print 23 May 2018. DOI: 10.3389/fped.2018.00142.
Fukui Y, Hishikawa N, Shang J, et al. Peripheral arterial endothelial dysfunction of neurodegenerative diseases. J Neurol Sci 2016; 366: 94–99.
Fichiers supplémentaires
Publiée
Numéro
Rubrique
Catégories
Licence
Merci de créditer les auteurs lors de toute citation : La Tunisie Médicale (2025)
Ce travail est disponible sous licence Creative Commons Attribution - Pas d'Utilisation Commerciale - Pas de Modification 4.0 International.
